12 Oct 2005 17:12
Cambridge Antibody Tech Group PLC12 October 2005 NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Name of company Cambridge Antibody Technology Group plc 2. Name of shareholder having a major interest OrbiMed Advisors. 3. Please state whether notification indicates that it is in respect of holdingof the shareholder named in 2 above or in respect of a non-beneficial interestor in the case of an individual holder if it is a holding of that person'sspouse or children under the age of 18 As in 2 above 4. Name of the registered holder(s) and, if more than one holder, the number ofshares held by each of them OrbiMed Advisors LLC 5. Number of shares / amount of stock acquired None 6. Percentage of issued class None 7. Number of shares / amount of stock disposed 330,000 Ordinary shares70,000 American Depositary Receipts 8. Percentage of issued class 0.774% 9. Class of security Ordinary 10 pence shares 10. Date of transaction 30 August 2005 11. Date company informed 11 October 2005 12. Total holding following this notification 1,893,500 of which1,667,400 are held in the form of ordinary 10 pence shares and226,100 are held in the form of American Depositary Receipts 13. Total percentage holding of issued class following this notification 3.667% 14. Any additional information Orbimed Advisors LLC has investment management discretion over the securitiesheld by the following entities: Caduceus Capital Master Fund LimitedCaduceus Capital II, L.P.UBS Eucalyptus Fund, L.L.C.UBS Eucalyptus Fund, LtdHFR SHC Aggressive Master TrustKnightsbridge Post Venture IV L.P.Knightsbridge Integrated Holdings, V, LPKnightsbridge Netherlands II, L.P.Knightsbridge Integrated Holdings IV Post Venture, LPKnightsbridge Post Venture III, LPKnightsbridge Netherlands I LPKnightsbridge Netherlands III - LPKnightsbridge Integrated Holdings II LimitedKnightsbridge Venture Completion 2005, L.P.Knightsbridge Venture Capital VI LPKnightsbridge Venture Capital IV, L.P.Knightsbridge Venture Capital III LP 15. Name of contact and telephone number for queries Justin Hoskins 01223 898589 16. Name and signature of authorised company official responsible for makingthis notification Justin Hoskins, Company Secretary Date of notification 12 October 2005 The FSA does not give any express or implied warranty as to the accuracy of thisdocument or material and does not accept any liability for error or omission.The FSA is not liable for any damages (including, without limitation, damagesfor loss of business or loss of profits) arising in contract, tort or otherwisefrom the use of or inability to use this document, or any material contained init, or from any action or decision taken as a result of using this document orany such material. This information is provided by RNS The company news service from the London Stock Exchange